Trials / Sponsors / HeartFlow, Inc.

HeartFlow, Inc.

Industry · 10 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI Coronary Artery Disease (CAD)	—	2026-03-11
Recruiting	Using CTA Measures to Define Cardiac Risk In NFL Alumni Coronary Artery Disease (CAD), Heart Disease, Coronary Atherosclerosis	—	2024-12-17
Active Not Recruiting	AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management Coronary Artery Disease	—	2024-03-27
Terminated	Assessing Diagnostic Value of Non-invasive FFR-CT (Fractional Flow Reserve - Computed Tomography) in Coronary Coronary Artery Disease	—	2022-07-15
Completed	The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))	—	2021-10-12
Completed	The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascula Coronary Artery Disease	N/A	2018-11-27
Completed	Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care Coronary Artery Disease	—	2015-07-01
Completed	The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) Coronary Artery Disease	—	2013-09-01
Completed	HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography Coronary Artery Disease	N/A	2012-09-01
Completed	Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography Coronary Artery Disease	N/A	2010-10-01